UNE PLATEFORME VACCINALE DE CLASSE MONDIALE - Linkinvax

Skip to content

Home
About Us
Research & development
Medias
Investors
- A unique project
- SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us

Menu

Home
About Us
Research & development
Medias
Investors
- A unique project
- SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us

Home
About Us
Research & development
Medias
Investors
- A unique project
- SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us

Menu

Home
About Us
Research & development
Medias
Investors
- A unique project
- SUBSCRIBE TO UPDATE
Join us (fr)
Contact Us

UNE PLATEFORME VACCINALE DE CLASSE MONDIALE

PrevPreviousLe Figaro – Vaccin contre le VIH : des résultats précoces encourageants en France

NextLinkinVAX completes first batch of ‘PanCov’ vaccine to prevent COVID-19Next

Contact Us

Headquarters :
Address : 2-10 Rue d’Oradour-sur-Glane 75015 Paris, France
Mail : contact@linkinvax.com
Tel : +33 (0) 189166213

Laboratories
VRI/Hôpital Henri Mondor
51, avenue du Maréchal De Lattre de Tassigny
94010 Créteil

BRI
3434 Live Oak St Ste 501, Dallas, TX 75204, États-Unis

Home

About Us

Why LinKinVax ?
Science
Team and skills
Partnering & featured deal
Company responsability

Research & development

Science
Our products
LinKinVax Pipeline

Media & Investors

A unique project
Press releases
News
Subscribe to update

© 2024 -

made by Création site web Grenoble